Jack of All Trades

Post-holiday light Tuesday: Palo Alto Networks beat (revenue +15%, EPS +27%) but sold off -7% on Q3 EPS guide miss ($0.78-0.80 vs $0.92) from $25B CyberArk integration costs. Platformization accelerating (RPO +23%, 70K customers) but near-term margin pressure—M&A execution risk dominates sentiment

Diversification strategies validated: Coinbase (12 products >$100M, Everything Exchange) sustaining EBITDA through crypto winter, Airbnb (Reserve Now Pay Later, FIFA supply engine) reaccelerating GBV to +16%, CBRE (data centers 14% EBITDA, $2B target) offsetting CRE cyclicality

Crypto, travel, and commercial real estate diverged: Coinbase missed (revenue -21.6% crypto winter) but resilient +0.6% on FCF $3.07B, Airbnb surged +7% on GBV +16% 2-yr high (Reserve Now Pay Later catalyst), CBRE beat on data centers (14% EBITDA, $2B 2026 target)—execution trumped cyclicality

Semiconductor equipment (AMAT AI/HBM dominance) and cloud networking (ANET 65% margins, $2.75B AI 2026) proved AI capex beneficiaries, EV scaling (RIVN R2 62-67K deliveries 2026) showed execution inflection, grocery tech (CART GTV +14% 3-yr high) validated platform defensibility

AI infrastructure diverged: Applied Materials crushed EPS +15% (AI equipment 20%+ growth 2026), Arista beat +4.6% revenue ($9B FY25, AI networking $2.75B target 2026), while Rivian rallied +17% on R2 Q2 launch (-$0.54 loss beat -$0.83) and Instacart surged +16% on GTV +14% 3-year high

Cisco's networking dominance (+21%, campus refresh, AI $2.1B orders) couldn't overcome valuation concerns (~20x post-37% rally), whereas McDonald's defensive execution (U.S. +6.8% comp, Grinch/Monopoly promotions working) justified ~28x premium amid consumer uncertainty—quality commands prices

Network infrastructure and consumer staples diverged: Cisco beat (+10% revenue, networking +21%, AI orders $2.1B) but fell -7% on in-line Q3 guide after 37% rally, while McDonald's crushed comps (+5.7% vs 3.9% est) validating value strategy despite cautious 2026 outlook on consumer pressures

Coke's record 31.2% margin couldn't offset volume stagnation (flat FY25) and 4-5% organic growth deceleration, while Gilead's 45% operating margin expansion (from 30%) and Yeztugo launch success prove HIV franchise durability to 2036—defensive quality diverges based on moat sustainability

Apollo's $938B AUM (+25% YoY) and >20% FRE growth guidance validates alternatives secular expansion, while BD's "New BD" reshaping (Waters exit, $4B proceeds) positions for stability but highlights medtech's low-growth reality amid tariff/China pressures

Alternative asset managers proved integrated model power as Apollo crushed estimates (+21% EPS beat, $305B origination, >20% FY26 FRE growth guide) while medtech BD executed portfolio transformation but faced margin compression from tariffs and China headwinds